Gastrointestinal perforation and cancer therapy: managing risk to achieve benefit.
Giantonio
Bruce J
BJ
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007416:Intestinal Perforation / Q000139:chemically induced* / Q000517:prevention & control*; D011379:Prognosis; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D016896:Treatment Outcome
D000970:Antineoplastic Agents